Oct 3 2006
Albemarle Corporation, a world leader in custom fine chemical manufacturing, has completed its acquisition of the assets, fine chemistry services and pharmachemicals business associated with the South Haven, Mich. facility of DSM Pharmaceutical Products (DSM), a business group of Royal DSM NV. The acquisition was completed effective September 30, 2006.
"The South Haven acquisition is another key move in our ongoing efforts to reposition the Fine Chemicals division around services and higher value activities," said John Nicols, Albemarle Vice President, Fine Chemicals. "Our customers and shareholders will benefit for years to come from South Haven's expertise and capabilities in cGMP development and manufacturing."
Albemarle's Fine Chemistry Services business, part of the company's Fine Chemicals division, is a leading provider of cGMP and non-GMP custom chemical manufacturing services, active ingredients, and intermediates for pharmaceutical, agricultural chemical and other customers worldwide.